GCP
DXCM icon

Garda Capital Partners’s DexCom DXCM Stock Holding History

Garda Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,400
Closed -$1.34M – 159
2025
Q2 		$1.34M Sell
15,400
-90,600
-85% -$7.1M 0.03% 327
2025
Q1 		$7.24M Buy
106,000
+94,000
+783% +$7.67M 0.18% 173
2024
Q4 		$933K Hold
12,000
– – 0.07% 160
2024
Q3 		$804K Sell
12,000
-36,500
-75% -$3M 0.02% 425
2024
Q2 		$5.5M Buy
48,500
+12,000
+33% +$1.52M 0.19% 145
2024
Q1 		$5.06M Buy
+36,500
New +$4.59M 0.21% 138
2023
Q2 		– Sell
-26,000
Closed -$3.02M – 380
2023
Q1 		$3.02M Buy
+26,000
New +$2.91M 0.15% 127

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Garda Capital Partners's DXCM Position: Q3 2025 in Review

Garda Capital Partners sold out of DexCom (DXCM) in Q3 2025, closing a stake of 6,652 shares — an estimated $581K sold.

Garda Capital Partners first reported a position in DXCM in Q2 2024 and held it in 5 quarters. The position peaked at $2.53M in Q1 2025. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Garda Capital Partners reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Garda Capital Partners sold 6,652 DexCom shares in Q3 2025, an estimated $581K.
  • Garda Capital Partners first reported a position in DexCom in Q2 2024 and held it in 5 quarters.
  • Garda Capital Partners's DexCom position peaked at $2.53M in Q1 2025.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Garda Capital Partners's 13F filing for Q3 2025, filed 10 Nov 2025.